Literature DB >> 2402719

Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.

P Lange1, J Nyboe, M Appleyard, G Jensen, P Schnohr.   

Abstract

The relation of ventilatory impairment and chronic mucus hypersecretion to death from all causes and death from obstructive lung disease (chronic bronchitis, emphysema and asthma) was studied in 13,756 men and women randomly selected from the general population of the City of Copenhagen. During the 10 year follow up 2288 subjects died. In 164 subjects obstructive lung disease was considered to be an underlying or a contributory cause of death (obstructive lung disease related death); in 73 subjects it was considered to be the underlying cause of death (obstructive lung disease death). Forced expiratory volume in one second, expressed as a percentage of the predicted value (FEV1% pred), and the presence of chronic phlegm were used to characterise ventilatory function and chronic mucus hypersecretion respectively. For mortality analysis the proportional hazards regression model of Cox was used; it included age, sex, pack years, inhalation habit, body mass index, alcohol consumption, and the presence or absence of asthma, heart disease, and diabetes mellitus as confounding factors. By comparison with subjects with an FEV1 of 80% pred or more, subjects with an FEV1 below 40% pred had increased risk of dying from all causes (relative risk (RR) = 5.0 for women, 2.7 for men), a higher risk of obstructive lung disease related death (RR = 57 for women, 34 for men), and a higher risk of obstructive lung disease death (RR = 101 for women, 77 for men). Chronic mucus hypersecretion was associated with only a slightly higher risk of death from all causes (RR = 1.1 for women, 1.3 for men). The association between chronic mucus hypersecretion and obstructive lung disease death varied with the level of ventilatory function, being weak in subjects with normal ventilatory function (for an FEV1 of 80% pred the RR was 1.2), but more pronounced in subjects with reduced ventilatory function (for an FEV1 of 40% pred the RR was 4.2). A similar though statistically non-significant trend was observed with regard to obstructive lung disease related death. This study shows that impaired lung function is very strongly related to total mortality, obstructive lung disease related mortality, and obstructive lung disease mortality and suggests that chronic mucus hypersecretion, in those with impaired ventilatory function, is also a significant risk factor for death from obstructive lung disease.

Entities:  

Mesh:

Year:  1990        PMID: 2402719      PMCID: PMC462624          DOI: 10.1136/thx.45.8.579

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  38 in total

1.  Twelve years spirometric changes among Paris area workers.

Authors:  F Kauffmann; D Drouet; J Lellouch; D Brille
Journal:  Int J Epidemiol       Date:  1979-09       Impact factor: 7.196

2.  Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium.

Authors:  C M Fletcher; N B Pride
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

3.  Effects of pulmonary function on mortality.

Authors:  T H Beaty; C A Newill; B H Cohen; M S Tockman; S H Bryant; H A Spurgeon
Journal:  J Chronic Dis       Date:  1985

4.  Alcohol and mortality: a U-shaped curve.

Authors:  M G Marmot; G Rose; M J Shipley; B J Thomas
Journal:  Lancet       Date:  1981-03-14       Impact factor: 79.321

5.  Nitrogen washout and mortality.

Authors:  H A Menkes; T H Beaty; B H Cohen; G Weinmann
Journal:  Am Rev Respir Dis       Date:  1985-07

6.  The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.

Authors:  R Peto; F E Speizer; A L Cochrane; F Moore; C M Fletcher; C M Tinker; I T Higgins; R G Gray; S M Richards; J Gilliland; B Norman-Smith
Journal:  Am Rev Respir Dis       Date:  1983-09

7.  Predictive clinical value of nutritional assessment factors in COPD.

Authors:  S R Braun; R M Dixon; N L Keim; M Luby; A Anderegg; E S Shrago
Journal:  Chest       Date:  1984-03       Impact factor: 9.410

8.  Prognosis after myocardial infarction: results of 15 year follow up.

Authors:  M A Merrilees; P J Scott; R M Norris
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-04

9.  The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow Study.

Authors:  M Krzyzanowski; M Wysocki
Journal:  Int J Epidemiol       Date:  1986-03       Impact factor: 7.196

10.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

View more
  35 in total

Review 1.  Airway hyperresponsiveness and COPD mortality.

Authors:  J Vestbo; E F Hansen
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease?

Authors:  M J Thomason; D P Strachan
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

Review 3.  Regulation of airway mucin gene expression.

Authors:  Philip Thai; Artem Loukoianov; Shinichiro Wachi; Reen Wu
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

4.  Chronic productive cough is associated with death in smokers with early COPD.

Authors:  Nirupama Putcha; M Bradley Drummond; John E Connett; Paul D Scanlon; Donald P Tashkin; Nadia N Hansel; Robert A Wise
Journal:  COPD       Date:  2013-10-15       Impact factor: 2.409

5.  Chronic Bronchitis: Where Are We Now?

Authors:  Yaniv Dotan; Jennifer Y So; Victor Kim
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04-09

Review 6.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

7.  Sex differences in function and structure of the quadriceps muscle in chronic obstructive pulmonary disease patients.

Authors:  Pilar Ausín; Juana Martínez-Llorens; Marina Sabaté-Bresco; Carme Casadevall; Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-12-06       Impact factor: 2.444

8.  Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia.

Authors:  A Frostad; V Soyseth; T Haldorsen; A Andersen; A Gulsvik
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

Review 9.  The role of CLCA proteins in inflammatory airway disease.

Authors:  Anand C Patel; Tom J Brett; Michael J Holtzman
Journal:  Annu Rev Physiol       Date:  2009       Impact factor: 19.318

10.  Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Authors:  M J Gizycki; K L Hattotuwa; N Barnes; P K Jeffery
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.